Literature DB >> 26183729

Clinical trials with herbal medicinal products in children: a literature analysis.

Peter Marquardt1, Karin Kaft, Karen Nieber.   

Abstract

Herbal medicinal products have been used since several decades for the health care of children. Nevertheless, well-controlled clinical studies with herbal medicinal products for children are rare. The authors' objective therefore was to evaluate clinical trials with herbal medicinal products in children, based on a literature search in PubMed and Web of Science. A total of 133 trials were identified. 90 studies were randomized, 32.2% were randomized and double-blinded. Most studies were performed in China, in the age group 6-12 years, and in children with respiratory diseases, most often herbal medicinal products with Hedera helix were tested. The analysis revealed that studies on herbal medicinal products were feasible in children. Although clinical trials have been found, this literature search have limitations and did not cover all studies performed. However, only few clinical trials of high quality were identified. Further studies therefore are urgently needed to support the good empirical findings.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26183729     DOI: 10.1007/s10354-015-0373-6

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  22 in total

Review 1.  Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents).

Authors:  J B Calixto
Journal:  Braz J Med Biol Res       Date:  2000-02       Impact factor: 2.590

2.  Herbs in pediatric and adolescent medicine.

Authors:  P Gardiner; K J Kemper
Journal:  Pediatr Rev       Date:  2000-02

Review 3.  Herbal remedies and children: do they work? Are they harmful?

Authors:  Alan D Woolf
Journal:  Pediatrics       Date:  2003-07       Impact factor: 7.124

4.  Acute bronchitis therapy with ivy leaves extracts in a two-arm study. A double-blind, randomised study vs. an other ivy leaves extract.

Authors:  Ute Cwientzek; Bertram Ottillinger; Petr Arenberger
Journal:  Phytomedicine       Date:  2011-07-30       Impact factor: 5.340

5.  [Treatment of ascaridiasis with garlic (Allium sativum)].

Authors:  R Campos; V Amato Neto; R E Castanho; A A Moreira; P L Pinto
Journal:  Rev Hosp Clin Fac Med Sao Paulo       Date:  1990 Sep-Oct

6.  Cranberry juice for the prevention of pediatric urinary tract infection: a randomized controlled trial.

Authors:  K Afshar; L Stothers; H Scott; A E MacNeily
Journal:  J Urol       Date:  2012-08-19       Impact factor: 7.450

7.  Evaluation of the antiparasitic effect of aqueous garlic (Allium sativum) extract in hymenolepiasis nana and giardiasis.

Authors:  S A Soffar; G M Mokhtar
Journal:  J Egypt Soc Parasitol       Date:  1991-08

8.  Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.

Authors:  Bahman Salehi; Reza Imani; Mohammad Reza Mohammadi; Jalil Fallah; Mohammad Mohammadi; Ahmad Ghanizadeh; Ali Akbar Tasviechi; Ardalan Vossoughi; Shams-Ali Rezazadeh; Shahin Akhondzadeh
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-10-05       Impact factor: 5.067

Review 9.  Evidence-based assessment of childhood injuries and physical risk-taking behaviors.

Authors:  Bryan T Karazsia; Keri J Brown Kirschman
Journal:  J Pediatr Psychol       Date:  2013-07-01

10.  Use of herbal medicinal products among children and adolescents in Germany.

Authors:  Yong Du; Ingrid-Katharina Wolf; Wanli Zhuang; Stefanie Bodemann; Werner Knöss; Hildtraud Knopf
Journal:  BMC Complement Altern Med       Date:  2014-07-02       Impact factor: 3.659

View more
  1 in total

1.  Pharmaco-epidemiological research on herbal medicinal products in the paediatric population: data from the PhytoVIS study.

Authors:  Karen Nieber; Esther Raskopf; Johanna Möller; Olaf Kelber; Robert Fürst; Kija Shah-Hosseini; Jaswinder Singh; Karin Kraft; Ralph Mösgens
Journal:  Eur J Pediatr       Date:  2019-12-11       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.